Complete MEDLINE and CINAHL search strategy. gan Naomi Assame (18136875)

Pynciau:

Table_3_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx gan Daniele Mercatelli (6031271)

“...<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. ...”

Table_1_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx gan Daniele Mercatelli (6031271)

“...<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. ...”

Table_2_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx gan Daniele Mercatelli (6031271)

“...<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. ...”

Development of immune factors over visits in the persistent and resolved CMA group as (A) scores and (B) loadings when using the persistent CMA group as a reference. gan Diana M. Hendrickx (1507435)

Patient Involvement in Preparing Clinical Research Peer-Reviewed Publications or Results Summaries: A Systematic Review gan Karen L. Woolley (4910764)

“...<div><b>Objective</b></div><div>Although patient involvement in results reporting is being encouraged, relevant evidence must be assessed before developing best practice guidelines. ...”

Spatial distribution of overall non-carcinogenic risk (HI) for (a) infants, (b) Children, (c) adult females, and (d) adult males posed by potential harmful substances of groundwate... gan Shanhu Xiao (22226759)

Mean d’ values as a function of time and warning condition, indicating participants’ ability to discriminate between memories for true and fake stories. gan Ciara M. Greene (7298963)

Pynciau:

Schematic of experimental procedure at Time 1 and Time 2. gan Ciara M. Greene (7298963)

Pynciau:

Mean truthfulness rating for each fake story in the original study (T1) and at follow-up (T2), presented separately for novel and repeated stories. gan Ciara M. Greene (7298963)

Pynciau:

Percentage of participants who reported a false memory for each fake story in the original study (T1) and at follow-up (T2). gan Ciara M. Greene (7298963)

Pynciau:

Mean behavioural intention scores for the targeted behaviours at Time 2, separately for participants who were or were not exposed to the associated misinformation at Time 1. gan Ciara M. Greene (7298963)

Pynciau:

Number and percentage of participants who report remembering and/or believing each fake story following the second debriefing at the end of the follow-up survey (Time 2). gan Ciara M. Greene (7298963)

Pynciau:

Percentage of participants who reported a false memory at follow-up for novel and repeated stories. gan Ciara M. Greene (7298963)

Pynciau:

False memories and truthfulness ratings at Time 2 for stories that were initially remembered or not remembered at Time 1. gan Ciara M. Greene (7298963)

Pynciau:

Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. gan Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. gan Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. gan Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. gan Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. gan Diana M. Hendrickx (1507435)